MTO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.035200E-01
Normal-vs-Stage2
4.305400E-01
Normal-vs-Stage3
2.738000E-01
Normal-vs-Stage4
6.078600E-01
Stage1-vs-Stage2
6.434800E-01
Stage1-vs-Stage3
1.066780E-01
Stage1-vs-Stage4
4.999200E-01
Stage2-vs-Stage3
1.198770E-01
Stage2-vs-Stage4
1.712440E-02
Stage3-vs-Stage4
5.159300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.360200E-01
Normal-vs-AfricanAmerican
4.727800E-01
Normal-vs-Asian
3.643800E-01
Caucasian-vs-AfricanAmerican
2.000800E-01
Caucasian-vs-Asian
3.100800E-01
AfricanAmerican-vs-Asian
9.912300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.060000E-01
Normal-vs-Female
4.809800E-01
Male-vs-Female
7.288100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.938600E-01
Normal-vs-Age(41-60Yrs)
4.870800E-01
Normal-vs-Age(61-80Yrs)
4.155600E-01
Normal-vs-Age(81-100Yrs)
4.457200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.070200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.705800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.650200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.344350E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.906000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.517600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.080800E-01
Normal-vs-Daily Drinker
3.048800E-01
Normal-vs-Weekly Drinker
3.791600E-01
Normal-vs-Occasional Drinker
4.585000E-01
Normal-vs-Social Drinker
4.838200E-01
Non Drinker-vs-Daily Drinker
3.238300E-02
Non Drinker-vs-Weekly Drinker
6.345200E-01
Non Drinker-vs-Occasional Drinker
5.248600E-01
Non Drinker-vs-Social Drinker
3.562000E-01
Daily Drinker-vs-Weekly Drinker
1.796420E-01
Daily Drinker-vs-Occasional Drinker
2.229800E-02
Daily Drinker-vs-Social Drinker
1.058080E-02
Weekly Drinker-vs-Occasional Drinker
3.786400E-01
Weekly Drinker-vs-Social Drinker
2.597800E-01
Occasional Drinker-vs-Social Drinker
8.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.399600E-01
Normal-vs-Grade 2
8.931800E-01
Normal-vs-Grade 3
9.339800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.931400E-01
Grade 1-vs-Grade 3
2.944800E-01
Grade 1-vs-Grade 4
6.399600E-01
Grade 2-vs-Grade 3
4.623000E-01
Grade 2-vs-Grade 4
8.931800E-01
Grade 3-vs-Grade 4
9.339800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.967800E-01
Normal-vs-NonDiabetic
4.097800E-01
Diabetic-vs-NonDiabetic
7.403000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.631800E-01
Normal-vs-NoPancreatitis
4.161800E-01
Pancreatitis-vs-NoPancreatitis
3.946200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.516800E-01
Normal-vs-N1
4.366000E-01
N0-vs-N1
7.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.118600E-01
Normal-vs-TP53-NonMutant
5.903400E-01
TP53-Mutant-vs-TP53-NonMutant
6.840800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
